TEVOGEN BIO HOLDINGS INC. - COMMON STOCK

1,0600

05-мая-25 16:45:00

15 мин. задержка

Акции

+0,0500

+4,95%

Сегодняшний диапазон

0,9830 - 1,0900

ISIN

N/A

Источник

NASDAQ

Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives

16 май 2024 14:00:00 Источник Nasdaq GlobeNewswire
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives

10 май 2024 17:40:49 Источник Nasdaq GlobeNewswire
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives

01 май 2024 08:05:00 Источник Nasdaq GlobeNewswire
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments

26 апр 2024 09:23:59 Источник Nasdaq GlobeNewswire
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers

11 апр 2024 08:05:00 Источник Nasdaq GlobeNewswire
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

03 апр 2024 08:05:00 Источник Nasdaq GlobeNewswire
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price

28 мар 2024 08:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.